Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 7, 2005, Pages 495-500

  Le Cam Duchez, Véronique ^a,b   Bagan Triquenot, Aude ^c   Ménard, Jean François ^c   Mihout, Bruno ^c   Borg, Jeanne Yvonne ^a,b,d  

^a UFR Medecine Pharmacie   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Cerebral thrombosis; Polymorphism (genetics); Risk factors; Thrombophilia; Venous thrombosis

Indexed keywords

ESTROGEN; PROTEIN C; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HAPLOTYPE; HUMAN; MALE; MUTATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

EID: 29144533179     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000184738.27723.b2     Document Type: Article

References (35)

1. Bloem BR, van Putten MJ, van der Meer FJ, van Hilten JJ, Bertina RM. Superior sagittal sinus thrombosis in a patient heterozygous for the novel 20210 A allele of the prothrombin gene [letter]. Thromb Haemost 1998; 79:235.
2. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10:87-111.
3. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31:1274-1282.
4. Martinelli I, Rosendaal FR, Vandenbroucke JP, Mannucci PM. Oral contraceptives are a risk factor for cerebral vein thrombosis. Thromb Haemost 1996; 76:477-478.
5. Ricchieri GL, Pizzolato G, Fabbri M, Patrassi GM, Sartori MT. Cerebral and vein thrombosis, transient protein S deficiency, and anticardiolipin antibodies. Am J Hematol 1996; 52:69-70.
6. Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997; 28:2363-2369.
7. Flusser D, Abu-Shakra M, Baumgarten-Kleiner A, Flusser G, Sukenik S. Superior sagittal sinus thrombosis in a patient with systemic lupus erythematosus. Lupus 1996; 5:334-336.
8. Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990; 21:1226-1231.
9. Lee MK, Ng SC. Cerebral venous thrombosis associated with antithrombin III deficiency. Aust NZ J Med 1991; 21:772-773.
10. Confavreux C, Brunet P, Petiot P, Berruyer M, Trillet M, Aimard G. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry 1994; 57:655-657.
11. Galan HL, McDowell AB, Johnson PR, Kuehl TJ, Knight AB. Puerperal cerebral venous thrombosis associated with decreased free protein S: a case report. J Reprod Med 1995; 40:859-862.
12. Enevoldson TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome? Q J Med 1990; 77:1255-1275.
13. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996; 27:1731-1733.
14. Kimber TE, Lloyd JV, Brophy BP, Thompson PD. Cerebral venous sinus thrombosis associated with factor V gene mutation. J Neurol Neurosurg Psychiatry 1996; 61:204-205.
15. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996; 27:1721-1723.
16. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338:1793-1797.
17. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210 → A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29:1765-1769.
18. Spek CA, Koster T, Rosendaal FR, Bertina RM, Reitsma PH. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 1995; 15:214-218.
19. Aiach M, Nicaud V, Alhenc-Gelas M, Gandrille S, Arnaud E, Amiral J, et al. Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 1999; 19:1573-1576.
20. Goudemand J, Caron C, De Prost D, Derlon A, Borg JY, Sampol J, et al. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Societe Francaise de Biologie Clinique and for the Groupe d'Etudes sur l'Hemostase et la Thrombose. Thromb Haemost 1997; 77:336-342.
21. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
22. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
23. Spek CA, Poort SR, Bertina RM, Reitsma PH. Determination of the allelic and haplotype frequencies of three polymorphisms in the promoter region of the human protein C gene. Blood Coagul Fibrinolysis 1994; 5:309-311.
24. Biousse V, Conard J, Brouzes C, Horellou MH, Ameri A, Bousser MG. Frequency of the 20210 G → A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29:1398-1400.
25. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. Q J Med 1998; 91:677-680.
26. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000; 83:229-233.
27. Le Cam-Duchez V, Gandrille S, Tregouet D, Alhenc-Gelas M, Emmerich J, Fiessinger JN, et al. Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation. Br J Haematol 1999; 106:889-897.
28. Gadelha T, Andre C, Juca AA, Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis 2005; 19:49-52.
29. Martinelli I, Taioli E, Palli D, Mannucci PM. Risk of cerebral vein thrombosis and oral contraceptives [letter]. Lancet 1998; 352:326.
30. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27:1724-1730.
31. Ludemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998; 29:2507-2510.
32. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 1996; 75:393-394.
33. Derex L, Philippeau F, Nighoghossian N, Trouillas P, Berruyer M. Postpartum cerebral venous thrombosis, congenital protein C deficiency, and activated protein C resistance due to heterozygous factor V Leiden mutation. J Neurol Neurosurg Psychiatry 1998; 65:801-802.
34. Weih M, Mehraein S, Valdueza JM, Einhaupl KM, Vetter B, Kulozik AE. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis. Stroke 1998; 29:1739-1740.
35. Liu XY, Gabig TG, Bang NU. Combined heterozygosity of factor V Leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis. Am J Hematol 2000; 64:226-228.